News

CAMBRIDGE, Mass. and BIRMINGHAM, Ala., Dec. 8, 2023/ PRNewswire/-- Alveolus Bio today announced a strategic scientific collaboration with BiomEdit, an emerging animal health biotechnology company ...
The investment is part of a multimillion-dollar Series A funding round for the UAB spinoff.
Alveolus Bio is one of the very few Alabama-based therapeutics companies ever to have received a FastTrack award from NIH. Alveolus Bio Secures NIH SBIR FastTrack Grant for Inhaled Biotherapeutic ...
Based in part on the Wyss team’s work in Alveolus Chips, Cantex licensed azeliragon for the treatment of COVID-19 and other inflammatory lung diseases in early 2022.
The new coronavirus packs a devastating punch. The new coronavirus packs a devastating punch. It penetrates deep into your lungs, causing our immune cells to go haywire and damage tiny air sacs ...
Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip. Nature Communications, 2022; 13 (1) DOI: 10.1038/s41467-022-29562-4 ...
The study team used a multimodal approach to investigate intercellular relationships that drive the formation of the alveolus. They discovered that alveolar type 1 (AT1) epithelial cells, which ...
Genomic, epigenomic, and biophysical cues controlling the emergence of the lung alveolus. Science, 2021; 371 (6534): eabc3172 DOI: 10.1126/science.abc3172 ...
You will take more than 600 million breaths in your lifetime - and each one of them helps keep you healthy. New research from Don Ingber's lab at the Wyss Institute revealed that breathing motions ...
Company: Alveolus Inc. Mission statement: Alveolus, Inc. will be the leading providers of stent technology in the emerging filed of non-vascular interventional stenting Type of company: Medical ...